**AI Founder Strikes Gold with ChatGPT for Doctors: Revolutionizing Healthcare One Click at a Time**
In the fast-paced world of medicine, where doctors are bombarded with an avalanche of information, one entrepreneur has found a goldmine by harnessing the power of artificial intelligence. Meet Daniel Nadler, co-founder and CEO of Open Evidence, a company that’s changing how doctors sift through mountains of medical research. With the staggering amount of data published every minute—around one new paper every 30 seconds—Nadler recognized that healthcare professionals need help keeping their heads above water. Hence, he rolled up his sleeves and got to work.
With a Harvard PhD and a successful previous venture under his belt—he sold his last company for a whopping $550 million—Nadler is no stranger to innovation. Open Evidence, founded in 2022 and based in sunny Miami, has developed proprietary algorithms that automatically scavenge through millions of peer-reviewed publications from top medical journals. This means that instead of drowning in a flood of complicated studies, doctors can quickly find relevant information, complete with full citations. Imagine being able to pinpoint exactly what the latest research says while juggling the care of 20 patients a day—talk about a game-changer!
What makes Open Evidence even more enticing is that it’s completely free for verified doctors to use. The company generates revenue through advertising, similar to how Google operates. Since its inception, Open Evidence has quickly become a go-to resource, signing up an astonishing 40% of physicians in the United States—over 430,000, to be precise. And they’re growing faster than a weed, adding around 65,000 new doctors each month. Currently, their advertising revenue is estimated at an annualized rate of $50 million. While this might seem modest for a tech startup, the explosive growth has attracted serious investment from big names like GV, Google’s venture capital arm, leading to a current company valuation of $3.5 billion.
Nadler’s personal journey with Open Evidence has made him a billionaire worth an estimated $2.3 billion, thanks to his savvy decision to invest $10 million of his own funds as a seed investor before seeking venture capital. Unlike many first-time entrepreneurs, Nadler confidently stated that he wanted to “bet on himself,” and his instincts paid off handsomely. Co-founder Zach Ziegler, the company’s young and dynamic chief technology officer, also has a significant stake in the company, valued at roughly $350 million.
As the volume of medical literature continues to explode—doubling every five years, mind you—Nadler’s solution is becoming increasingly relevant. Not only does Open Evidence streamline the research process for doctors, but it also avoids cumbersome regulatory hurdles. Since the software does not qualify as diagnostic, it is free from the FDA approval process that often bogs down medical innovations. Doctors are now turning to Open Evidence for approximately 8.5 million consultations each month, solidifying its place as a favorite tool among busy practitioners.
Overall, Nadler’s vision for Open Evidence has the potential to transform healthcare as we know it. By marrying cutting-edge AI technology with the essential needs of healthcare providers, he is paving the way for a future where information is not just easier to access but also more trustworthy. As the healthcare landscape continues to evolve, one thing is clear: Daniel Nadler is a name to watch in the world of health tech. After all, when it comes to making medicine more efficient, his approach is as refreshing as a morning cup of joe.